The present retrospective study was carried out on 29 CML patients under TKIs therapy, and all of them were positive for the p210 BCR-ABL rearrangement at diagnosis. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.